2016 PREVIEW: Japan - Price Cuts Loom But Regulatory Outlook Good
This article was originally published in PharmAsia News
As Japan rings in the Year of the Monkey, is there mischief in store? Certainly, some pharma companies operating in the country are bracing for possible big price cuts for fast-growing blockbuster on top of the regular biennial price revision in April. But the regulatory outlook seems generally bright.
Register for our free email digests: